Gene · 1830
Papers2,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical improvement of pemphigus-like mucocutaneous disease in a patient with CLL following initiation of zanubrutinib: a case report. | Front Immunol | 2026 | 42812523 | PubTator, text mining | PubMed |
| Two opposite effects of desmoglein 3 on the growth of oral squamous cell carcinoma between anchorage -dependent and -independent conditions. | PLoS One | 2026 | 42789540 | PubTator, text mining | PubMed |
| Coexistence of Erythrodermic Psoriasis and Bullous Pemphigoid: A Case Report. | Clin Cosmet Investig Dermatol | 2026 | 42770037 | PubTator, text mining | PubMed |
| Efficacy and safety of subcutaneous efgartigimod with prednisone in moderate-to-severe pemphigus (ADDRESS): a global, phase III, randomised controlled, double-blind trial. | Br J Dermatol | 2026 | 42723554 | PubTator, text mining | PubMed |
| Case report: Atypical SJS/TEN-like fulminant pemphigus vulgaris: diagnostic challenges and the potential impact of anti-Dsg1 titers and CMV reactivation. | Front Immunol | 2026 | 42698938 | PubTator, text mining | PubMed |
| Acantholytic Blistering of the Oroesophageal Mucosa Due to Homozygous DSG3 Pathogenic Missense Variant. | JAMA Dermatol | 2026 | 42684697 | PubTator, text mining | PubMed |
| Rituximab remodels the circulating immune landscape in pemphigus vulgaris revealed by high-dimensional immune profiling. | J Transl Autoimmun | 2026 | 42602981 | PubTator, text mining | PubMed |
| IgG subclasses and their significance in pemphigus disease progression monitoring. | Front Immunol | 2026 | 42591548 | PubTator, text mining | PubMed |
| Anti-BP180 Mucosal Membrane Pemphigoid With a History of Maxillary Carcinoma With Antibodies to 190 kDa Periplakin and 210 kDa Envoplakin: A Case Report. | J Dermatol | 2026 | 42543823 | PubTator, text mining | PubMed |
| Chemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Diagnosis of Pemphigoid and Pemphigus: A Comparative Study. | Int J Mol Sci | 2026 | 42511614 | PubTator, text mining | PubMed |
| Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor). | Front Immunol | 2026 | 42459647 | PubTator, text mining | PubMed |
| APOA1, DEFB103A_DEFB103B and DSG3 Are Novel Circulating Biomarkers of Psoriasis. | Int J Mol Sci | 2026 | 42450078 | PubTator, text mining | PubMed |
| MiR-125b-5p promotes pemphigus vulgaris pathogenesis by modulating desmosome structures. | Biosci Rep | 2026 | 42438965 | PubTator, text mining | PubMed |
| A Dsg3-specific pemphigus autoantibody induces formation of immature desmosomes associated with impaired adhesion. | Tissue Barriers | 2026 | 42430447 | PubTator, text mining | PubMed |
| Keratins and desmosomal proteins: Utility for molecular subtype identification in muscle-invasive bladder cancer. | Virchows Arch | 2026 | 42406031 | PubTator, text mining | PubMed |
| Correlation of Clinical and Histopathological Features With Anti-Desmoglein Antibody Profile in Pemphigus Patients. | Int J Dermatol | 2026 | 42387665 | PubTator, text mining | PubMed |
| Tumor Invasive Border Index (TIBI) in colorectal cancer: linking infiltrative morphology to molecular insights. | J Pathol | 2026 | 42312545 | PubTator, text mining | PubMed |
| Pemphigus vulgaris-a blistering clinical enigma: case report. | BMC Oral Health | 2026 | 42304369 | PubTator, text mining | PubMed |
| Protocol to quantify desmoglein 3 tension at cell-cell adhesions using FRET-based tension sensors. | STAR Protoc | 2026 | 42301820 | PubTator, text mining | PubMed |
| Prolactin as a Biomarker of Disease Activity in Autoimmune Bullous Disorders-A Case-Control Study. | Indian Dermatol Online J | 2026 | 42301678 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1830/papers